Comparison of thewound healing effects of vascular endothelial growth factor a (VEGF-A) and transforming growth factor beta 3 (TGF-β3) on gingival cells

Abstract

Each tissue has its own anatomy and physiology. The deterioration of these structures by various effects (crushing, puncture, pathogens, etc.) is called as wound. The tissue exposed to these effects wants to gain the same function and anatomy. This phenomenon is called wound healing. Wound healing is a process that involves many reactions and cytokines. Since it is known that TGF-β3 and VEGF-A proteins which are among these cytokines, play an active role in wound healing stages. In the present study, it was decided to examine the wound healing effects of the non human gingival fibroblast cells comperatively. Wound healing process under the influence of these cytokines was performed by in vitro scratch analysis which is known as easy, reliable and cheap technique. In this context, firstly cell viability analysis was performed to determine the most effective dose for inducing cell proliferation. After this experimental step, gingival cells were incubated for 72 hours with suitable TGF-β3 and VEGF-A doses. As a result of the study, it was concluded that TGF-β3 and VEGF-A proteins are not cytotoxic and have a wound-healing effect on gingival fibroblast cells.

Keywords

• TGF-β3
• VEGF-A
• Gingival fibroblast cells
• wound healing.

References

1. Werner, S.; Grose, R. Physiologica reviews. 2003, 83(3):835-70.
2. Ahmet, Ü; Aydın, H.; Tüzün, İ.S. Karşıdağ, Mühendislik Bilimleri ve Tasarım Dergi. 2014, 2(3):141-5.
3. Hormozi, M.; Assaei, R. Boroujeni, M.B. Biomedicine&Pharmacotherapy. 2017, 88:610-6.
4. Aktaş, Ş. ANKEM Derg. 2012, 26: 217-222
5. Barrientos, S.; Stojadinovic, O.; Golinko, M.S.; Brem, H.; Tomic‐Canic, M. Wound repair regen. 2008, 16(5):585-601.
6. Gence, H. Ankara Üniversitesi Tıp Fakültesi Mecmuası. 2008, 61(03):171-9.
7. Arthur, C.; Guyton, M., D.; John, E. Elsevier. 2006, p. 457-8.
8. Monaco, JL.; Lawrence, W.T. Clinics in plastic surgery. 2003, 30(1):1-12.

9. Uzun, E. Diyabetik Ratlarda Topikal Vasküler Endotelyal Büyüme Faktörü (Vegf) Uygulamasının Yara Dokusundaki Oksidatif Olaylar Üzerine Etkisinin Araştırılması. Uzmanlık tezi. Gazi Üniversitesi 2013.
10. Witte, MB.; Barbul, A. Surgical Clinics of North America. 1997, 77(3):509-28.
11. Johnson, KE.; Wilgus, TA. Advances in wound care. 2014, 3(10):647-61.
12. Pappas, P.J.; You, R.; Rameshwar, P. J VascSurg. 1999, 30: 1129-45
13. Dvorak, L.F. Brown.; M, Detmar.; A.M. Dvorak. Am J Pathol. 1995, 146(5):1029–39
14. Chapple, C. C.; Kumar, R.K.; Hunter, N. J Oral PatholMed. 2000, 29:500–06.
15. Connolly, D.T.; Olander, J.V.; Heuvelman, D.; Nelson, R.; Monsell,R.; Siegel, N.; Haymor, B. L..E; Leingruber, R.; Feder, J. J BiolChem. 1989, 264(20):17–24.
16. Cao, L.; Jiao, X; Zuzga, D.S.; Liu, Y; Fong, D.M.; Young, D. NatGenet. 2004, 36(8):827–35.
17. Hoeben. A.; Landuyt. B.; Highley. M.S.; Wildiers. H.; Van Oosterom. A.T.; De Bruijn E.A. Pharmacol Rev. 2004,56 (4), 549–80
18. Dvorak, H.F.; Detmar, M.; Claffey, K.P.; Nagy, J.A.; Van de Water, L.; Senger, D.R.. Int. Arch. Allergy Immunol. 1995,107 (1-3), 233–235.
19. Valluru, M.; Staton, C.A.; Reed, M.W.; Brown, N.J. Front. Physiol. 2011, 2, 89.
20. Laverty, H.G.; Wakefield, L.M.; Occleston, N.L.; O’Kane, S.; Ferguson, M.W. Cytokine Growth Factor Rev. 2009, 20, 305–317.
21. Öztopalan, D.F.; Işık. R.; Durmuş. A.S. Dicle Üniv Vet Fak dergisi. 2017, 10:83-8.
22. Coşkun, Ö.; Uzun, G.; Dal, D.; Gülhane Tıp Dergi 2016, 58:207-28
23. Massague, J. Nat. Rev. Mol. Cell Biol. 2012, 13, 616–630.
24. Sprugel,.KH.; Mcpherson. J.M.; Clowes. A. Am J Pathol 1987, 129:601-13.
25. Kuduğ, C, H.; Erden, T. S.; Gökçe, İ. International Journal Of Peptide Research And Therapeutics, 2021. 27, pages1989–2001
26. Wongkhum, C.; Chotigeat, W.; Legat-Kedjarune, U. Mol Med Reb. 2018, Apr; 17(4):6100-6108.
27. Azadeh, J.; Xiujuan, Z.; ChangChih, L.; Ali, N. J Clin Lab Anal. 2017, Aug;54(6):633-48.
28. Ahmed, S.; Liu, CC.; Nawshad, A. Dev Biol. 2007, 309:193–207.
29. Nawshad, A.; Medici, D., Liu, C.C.; Hay, ED. J Cell Sci. 2007, 120:1646–1653
30. Kaartinen, V.; Cui, XM.; Heisterkamp, N.; Groffen, J.; Shuler, C.F. Dev Dyn. 1997, 209:255–260.
31. Lindhe, J.; Lang, N.P.; Berglundh, T.; Giannobile, W.V.; Sanz, M.; Wiley Blackwell; 2015.
32. Kohale, B. R.; Agrawal, A. A.; Raut, C.P. Journal of Indian Society of Periodontology, 2018, 22(5), 419.
33. Avani, Y.; Lerman, P.; Mint, S.; Kiviti, S. Develop Medicine and Child Neurology. 31:538-542, 1989.
34. Tayhan, E, S.; Bilgin, S.; Yıldırım, A.; Koç, E.; Ceylan, M. Chemistry & Biotmersity, 2022
35. İspir, E; İkiz, M; İnan, A.; Sünbül, A. B.; Tayhan, S. E.; Bilgin, S.; Köse, M.; Elmastaş, M. Journal of Molecular Structure. 2019, 1182, 63–71
36. Tayhan, S. E.; Bilgin, S.; Elmastaş, M. International Journal of Chemistry and Technology. 2018, 2, 16–19.
37. Zhu, Y.; Zhou, Ç.; Wang, Y. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2004 PMID: 15586711
38. Ling, Y .; Wayne, A.; Border, Y. H.; Nancy, A. Kidney Int. 2003, Sep;64(3):844-56.
39. Zhang, Y.; Liu, J.; Zou, T.; Qi, Y.; Yi, B.; Dissanayaka, W.L.; Zhang, C. Stem Cell Resther. 2021, May 10;12(1):281.
40. Prapulla, D.V.; Sujatha, P.B.; Pradeep, A.R.; J Periodontol. 2007, Sep;78(9):1783-7.
41. Nawshad, A.; Lagamba, D.; Hay, E.D. Arch Oral Biol. 2004, 49:675–689.